Literature DB >> 1467194

Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.

M B Tyers1.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1467194      PMCID: PMC2149629     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  1 in total

1.  5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.

Authors:  G A Higgins; G J Kilpatrick; K T Bunce; B J Jones; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

  1 in total
  3 in total

1.  A Flawed Design Produces Flawed Results.

Authors:  Gary Peltz
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

Review 2.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

3.  Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial.

Authors:  Gary Peltz; Lauren M Jansson; Susan Adeniyi-Jones; Carol Cohane; David Drover; Steven Shafer; Meiyue Wang; Manhong Wu; Balaji Govindaswami; Priya Jegatheesan; Cynthia Argani; Salwa Khan; Walter K Kraft
Journal:  J Perinatol       Date:  2022-08-27       Impact factor: 3.225

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.